# An Investigational Study to Evaluate Experimental Medication SYHX1901 Tablets With Moderate to Severe Plaque Psoriasis

> **NCT05858047** · PHASE2 · COMPLETED · sponsor: **CSPC Ouyi Pharmaceutical Co., Ltd.** · enrollment: 93 (actual)

## Conditions studied

- Effects, Drug Side

## Interventions

- **DRUG:** Placebo
- **DRUG:** SYHX1901

## Key facts

- **NCT ID:** NCT05858047
- **Lead sponsor:** CSPC Ouyi Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-11
- **Primary completion:** 2024-02-21
- **Final completion:** 2024-02-21
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2024-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05858047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05858047, "An Investigational Study to Evaluate Experimental Medication SYHX1901 Tablets With Moderate to Severe Plaque Psoriasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05858047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*